Skip to main content

Immunoassays for Immuno-Oncology Research

Immunoassay screening to validation Workflow

From early-stage multiplex biomarker discovery, to target analyte validation, to the study of cytokine release syndrome (CRS), Bio-Techne has a wide range of multiplex, single analyte, and automated immunoassays to suit your needs.


Why Bio-Techne?

  • Unwavering commitment to quality and consistency
  • More than 30 years of experience in immunoassay development and manufacturing
  • Extensive range of target analytes in multiple immunoassay formats

Multiplex with R&D Systems™ Luminex® Assays

R&D Systems Luminex assays are highly flexible- enabling you to select only the analytes you want to interrogate. 

Cytokine Panels

Immune Checkpoint Assays

Build Your Own Panel with Luminex Assay Customization Tool

Single Analyte Analysis with Quantikine™ ELISAs

Quantikine ELISAs are the most referenced ELISA kits on the market. Choose from our wide range of over 600 assays across seven species.  

Cytokine ELISAs

Immune Checkpoint ELISAs

Get Real-Time Data with Simple Plex™ Assays

Save time and precious sample with Simple Plex assays on the automated Ella platform. Ella reduces user error and delivers results in 90 minutes. Learn more at

Cancer Immunoassays

Cell Therapy Immunoassays

Cytokine Immunoassays

Immunoassays, ELISA kits and Luminex assays

DuoSet™ Development ELISAs

A customizable development ELISA to meet your specific research needs. DuoSets are an economical, flexible alternative for the experienced ELISA-user.  

Cytokine Assays | Immune Checkpoint Assays 

CTLA-4IDO | PD-1 | PD-L1  

Proteome Profiler antibody arrays

Proteome Profiler™ Antibody Arrays

Proteome Profiler Antibody Arrays are the economical discovery choice for early-stage immuno-oncology research. Measure more than 100 proteins in a single sample!

Angiogenesis Arrays | Cancer Arrays

Cytokine Arrays | Immuno-oncology Arrays

Featured Immunoassays for Immuno-Oncology Research

Custom Immunoassay Services

Custom ELISA Services

Take advantage of our decades of ELISA development experience to accelerate your custom project.

: Bio-Techne’s Luminex Assay from its R&D Systems brand combines accuracy and performance with the breadth of content.

Custom Luminex Services

Utilize our comprehensive collection of in-house proteins and antibodies to create a custom Luminex panel to fit your research needs.

Additional Immuno-Oncology Content

ELISA High Sensitivity Immunoassays

Quantify IFN-Gamma with Confidence

Cytokine Release Syndrome (CRS) is an adverse effect of cellular therapy. Interferon gamma (IFN-gamma) secretion can be an early and prominent feature of CRS. Download this application note to see how Quantikine High Sensitivity ELISAs are used to detect IFN-gamma in serum and plasma.

Immuno-oncology research cell molecule

Proteins for Immune Checkpoint Research

Immune checkpoint proteins play a central role in regulating the activities of multiple immune cell types and are being investigated as some of the most promising targets for cancer immunotherapy research. Bio-Techne offers an extensive range of R&D SystemsTM immune checkpoint proteins for studying common and emerging immune checkpoint targets, including PD-1, CTLA-4, LAG-3, TIGIT, TIM-3, butyrophilins, and LILR family members.

Immuno-Oncology Checkpoint Proteins

Current and Emerging Immune Checkpoint Targets for Immuno-Oncology Research

Download the eBook to learn about existing and emerging immune checkpoint targets.

Resources for Immuno-Oncology Research


Immuno-Oncology Workflow

Expedite your immuno-oncology workflow: 1. Isolate and Activate, 2. Visualize and Characterize, 3. Verify and Quantify.

Stem Cells

Cell and Gene Therapy Solutions

Pioneering cell and gene therapy tools to simplify your workflow.

Resources for Cell Therapy Manufacturing

GMP Capabilities

Find out about our Good Manufacturing Practice (GMP) processes and services.

GMP Proteins

Learn more about our new, state-of-the-art GMP manufacturing facility.

GMP Small Molecules

Use GMP small molecules as ancillary materials for the manufacture of stem cell therapies.